Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1984-02-29
1986-03-18
Rizzo, Nicholas S.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
544 26, 544 21, C07D50148, A61K 31545
Patent
active
045769370
ABSTRACT:
A new cephalosporin compound, 7-D-mandelamido-3-(1-sulfomethyltetrazol-5-yl) thiomethyl-3-cephem-4-carbo xylic acid monosodium salt, having unique antibacterial activity and advantageously high stability, is disclosed. Pharmaceutical compositions comprising the new cephalosporin monosodium salt are also disclosed.
REFERENCES:
patent: 3376310 (1968-04-01), Abbott et al.
patent: 3516997 (1970-06-01), Takano et al.
patent: 3819623 (1974-06-01), Takano et al.
patent: 4048311 (1977-09-01), Berges
Foggio Richard D.
Lourie Alan D.
Rizzo Nicholas S.
SmithKline Beckman Corporation
Williams Janice E.
LandOfFree
7 -D-Mandelamido-3(1-sulfomethyltetrazol-5-yl)thiomethyl-3-cephe does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 7 -D-Mandelamido-3(1-sulfomethyltetrazol-5-yl)thiomethyl-3-cephe, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 7 -D-Mandelamido-3(1-sulfomethyltetrazol-5-yl)thiomethyl-3-cephe will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2306209